Table 3.
Variables | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95%CI | p value | HR | 95%CI | p value | |
SSR2 expression | 3.59 | 1.65-7.83 | 0.02 | 3.32 | 1.44-7.65 | 0.01 |
(High vs. Low) | ||||||
Gender | 0.88 | 0.31-2.51 | 0.81 | |||
(Male vs. Female) | ||||||
Age (years) | 0.65 | 0.32-1.31 | 0.23 | |||
(≥50 vs.<50) | ||||||
AFP (ng/mL) | 1.01 | 0.46-2.22 | 0.99 | |||
(≥200 vs. <200) | ||||||
Size (cm) | 1.68 | 0.80-3.51 | 0.17 | |||
(≥5 vs. <5 ) | ||||||
Tumor nodule number | 0.77 | 0.29-2.06 | 0.61 | |||
(≥2 vs.<2) | ||||||
Cirrhosis | 1.66 | 0.82-3.39 | 0.16 | |||
(Positive vs. Negative) | ||||||
MVI | 2.53 | 1.22-5.24 | 0.01 | 2.20 | 1.00-4.84 | 0.05 |
(Positive vs. Negative) | ||||||
Stage | 3.71 | 1.45-9.51 | 0.01 | 3.05 | 1.10-8.51 | 0.03 |
(Late vs. Early) | ||||||
Encapsulation invasion | 2.44 | 1.14-5.23 | 0.02 | 1.49 | 0.64-3.47 | 0.36 |
(Positive vs. Negative) | ||||||
Grade | 1.14 | 0.42-3.11 | 0.80 | |||
(Poor vs. Well) |